Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasallergy-and-immunology

Paeds Vivas · allergy-and-immunology

Immunoglobulin replacement and antimicrobial prophylaxis — branching viva

Branching viva on confirming the indication for immunoglobulin replacement, choosing the route, dosing to outcome, and layering antimicrobial prophylaxis in a child with antibody deficiency.

branching clinical structured oral1 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
Outpatient clinic: a six-year-old boy with X-linked agammaglobulinaemia is established on intravenous immunoglobulin every four weeks. He has had three breakthrough pneumonias this year despite a trough IgG in the lower half of the normal range, and his family lives two hours from the hospital. The examiner asks: what is your framework, what are the reassessment questions before changing the dose, what are the advantages of switching to subcutaneous immunoglobulin, and what role does antimicrobial prophylaxis play — then branches to a child with specific antibody deficiency and asks you to justify why you would NOT start immunoglobulin first.

Opening question

Take me through your framework when a child established on immunoglobulin replacement presents with breakthrough infection despite an apparently adequate trough. [2] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol, 2015.PMID 26371839
  2. [2]Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol, 2017.PMID 28041678
  3. [3]Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol, 2006.PMID 16580469
  4. [5]Suez D, Stein M, Gupta S, et al. Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20% in Patients with Primary Immunodeficiency Diseases in North America. J Clin Immunol, 2016.PMID 27582171
  5. [6]Joud Hajjar, Nguyen AL, Constantine G, et al. Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency. J Clin Immunol, 2020.PMID 31758281
  6. [8]Abolhassani H, Sadaghiani MS, Aghamohammadi A, et al. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol, 2012.PMID 22730009
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousImmune dysregulation, lymphoproliferation and autoinflammatory disease — vivaallergy-and-immunologyNextInsect-sting hypersensitivity — branching vivaallergy-and-immunology